Xalkori 200 MG capsule 60S
Ended Awarded
- Contract number
- SPE2DB25FBJM9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,419
Award facts
- Contract value 100% obligated
- $14,419.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,419.30 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Xalkori 200 mg, a targeted cancer therapy medication. This competitive, firm fixed-price contract was awarded on September 16, 2025, with an ultimate completion date of October 7, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle running through December 2026 that provides comprehensive global pharmaceutical support across multiple therapeutic domains.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver diverse pharmaceutical products and medical supplies through open competition. As a child contract under the SPE2DX IDC, this Xalkori delivery order reflects the company's role in supporting the Defense Health Agency and other federal healthcare systems with specialty medications necessary for patient care across the military healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FBJM9?
SPE2DB25FBJM9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FBJM9 worth?
The government has obligated $14,419 on SPE2DB25FBJM9.
Is contract SPE2DB25FBJM9 an order under another contract?
Yes. SPE2DB25FBJM9 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBJM9 competed?
The extent of competition for SPE2DB25FBJM9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award